Mylan Institutional LLC recalls Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx onl
Recalled June 9, 2021 · FDA recall D-0601-2021 · Mylan Institutional
Hazard
Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901. · FDA Class III
Units
2,131 cartons
Sold at
Nationwide within the United States
Description
Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
Product
Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02
Manufacturer(s)
Mylan Institutional LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →